GLUE R&D Expense Growth
Monte Rosa Therapeutics Inc · R&D Expense Growth
GLUE R&D Expense Growth
Latest reported16.40%period ending
GLUE FY R&D Growth (YoY) (0.00% → 16.40%)
Latest values, visible window
High-resolution chart · PNG
GLUE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 16.4005% | |
| 15.7192% | |
| 23.4996% | |
| 48.8251% | |
| 143.5444% | |
| 219.2925% | |
| 0% |